TROP2 marks relapse-driving colorectal cancer cells and opens path to targeted treatment

A squad led by researchers from the German Cancer Research Center (DKFZ) and the HI-STEM Stem Cell Institute has discovered a promising caller attack to treating precocious colorectal cancer. The study, published successful Nature, identifies a cardinal marker of peculiarly assertive and treatment-resistant colorectal crab cells.